Neofect Co.Ltd Market Cap ($34.66 Million)
Market Cap & Net Worth: Neofect Co.Ltd (290660)
Neofect Co.Ltd market cap. Neofect Co.Ltd (KQ:290660) has a market capitalization of $34.66 Million (₩51.15 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #23057 globally and #1557 in its home market, demonstrating a -12.66% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Neofect Co.Ltd's stock price ₩1194.00 by its total outstanding shares 42837888 (42.84 Million). Also see Neofect Co.Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Neofect Co.Ltd Market Cap History (2018–2026)
Neofect Co.Ltd market cap history from 2018 to 2026. Data shows change from $191.37 Million to $34.66 Million (-19.72% CAGR). Check Neofect Co.Ltd stock price for real-time trading data and today's change.
Index Memberships
Neofect Co.Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.02% | #778 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.02% | #778 of 1384 |
Weight: Neofect Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Neofect Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Neofect Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Neofect Co.Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Neofect Co.Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $191.37 Million | $5.65 Billion | -$9.63 Billion | 0.03x | N/A |
| 2019 | $135.56 Million | $12.31 Billion | -$15.84 Billion | 0.01x | N/A |
| 2020 | $100.30 Million | $18.62 Billion | -$15.01 Billion | 0.01x | N/A |
| 2021 | $91.01 Million | $23.16 Billion | -$5.04 Billion | 0.00x | N/A |
| 2022 | $40.50 Million | $26.20 Billion | -$9.62 Billion | 0.00x | N/A |
| 2023 | $36.09 Million | $26.61 Billion | -$4.96 Billion | 0.00x | N/A |
| 2024 | $25.66 Million | $21.11 Billion | -$951.43 Million | 0.00x | N/A |
| 2025 | $21.02 Million | $16.05 Billion | -$12.30 Billion | 0.00x | N/A |
Competitor Companies of 290660 by Market Capitalization
Companies near Neofect Co.Ltd in the global market cap rankings as of November 4, 2026. Also see Neofect Co.Ltd assets under control for a full breakdown of the balance sheet.
Key companies related to Neofect Co.Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Neofect Co.Ltd (2018–2026)
Market capitalization of Neofect Co.Ltd from 2018 to today. Between 2018 and today, Neofect Co.Ltd's market cap moved from $191.37 Million to $ 34.66 Million, with a yearly change of -19.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩34.66 Million | +64.92% |
| 2025 | ₩21.02 Million | -18.10% |
| 2024 | ₩25.66 Million | -28.88% |
| 2023 | ₩36.09 Million | -10.90% |
| 2022 | ₩40.50 Million | -55.50% |
| 2021 | ₩91.01 Million | -9.26% |
| 2020 | ₩100.30 Million | -26.01% |
| 2019 | ₩135.56 Million | -29.17% |
| 2018 | ₩191.37 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Neofect Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $34.66 Million USD |
| MoneyControl | $34.66 Million USD |
| MarketWatch | $34.66 Million USD |
| marketcap.company | $34.66 Million USD |
| Reuters | $34.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Neofect Co.Ltd
Dynamic solution Co.,Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high… Read more